MedTrace Logo

A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix

NCT02765919 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-07-16

No results posted yet for this study

Summary

The purpose of this study is to compare two different brachytherapy treatment option in locally advanced carcinoma of uterine cervix. Brachytherapy of two fractions of 9 Gy is effective in locoregional control and more convenient in terms of cost and time than 7 Gy brachytherapy of 3 fractions in management of locally advanced carcinoma of cervix.

Conditions

  • Squamous Cell Carcinoma of Cervix

Interventions

RADIATION

HDR Brachytherapy of 9 Gy in 2 fractions

Two fractions of HDR brachytherapy following standard dose CCRT in locally advanced carcinoma cervix

RADIATION

HDR Brachytherapy of 7 Gy in 3 fractions

Three fractions of HDR Brachytherapy following standard dose CCRT in locally advanced carcinoma cervix

Sponsors & Collaborators

  • Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    lead OTHER

Principal Investigators

  • Mohammad Abdul Bari, MBBS,MPhil · Associate Professor,dept.of Oncology,BSMMU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-12-31
Completion
2017-07-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765919 on ClinicalTrials.gov